Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

515 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Relationship between "Blue Space" Proximity and Children's Weight Status, Health Behaviors, and Health-Related Quality of Life among a Sample of Regional Victorian Primary School Children.
Crooks N, Becker D, Gaskin CJ, Nichols M, Bolton KA, Orellana L, Fraser P, Le H, Brown A, Bell C, Bliss J, Allender S, Strugnell C. Crooks N, et al. Among authors: bliss j. Child Obes. 2022 Oct;18(7):494-506. doi: 10.1089/chi.2021.0219. Epub 2022 Mar 10. Child Obes. 2022. PMID: 35271381
Healthy together Victoria and childhood obesity study: effects of a large scale, community-based cluster randomised trial of a systems thinking approach for the prevention of childhood obesity among secondary school students 2014-2016.
Strugnell C, Orellana L, Crooks N, Malakellis M, Morrissey B, Rennie C, Hayward J, Bliss J, Swinburn B, Gaskin CJ, Allender S. Strugnell C, et al. Among authors: bliss j. BMC Public Health. 2024 Feb 2;24(1):355. doi: 10.1186/s12889-024-17906-2. BMC Public Health. 2024. PMID: 38308292 Free PMC article. Clinical Trial.
Final analysis of the ALTTO trial: adjuvant trastuzumab in sequence or in combination with lapatinib in patients with HER2-positive early breast cancer [BIG 2-06/NCCTG N063D (Alliance)].
de Azambuja E, Piccart-Gebhart M, Fielding S, Townend J, Hillman DW, Colleoni M, Roylance R, Kelly CM, Lombard J, El-Abed S, Choudhury A, Korde L, Vicente M, Chumsri S, Rodeheffer R, Ellard SL, Wolff AC, Holtschmidt J, Lang I, Untch M, Boyle F, Xu B, Werutsky G, Tujakowski J, Huang CS, Baruch NB, Bliss J, Ferro A, Gralow J, Kim SB, Kroep JR, Krop I, Kuemmel S, McConnell R, Moscetti L, Knop AS, van Duijnhoven F, Gomez H, Cameron D, Di Cosimo S, Gelber RD, Moreno-Aspitia A. de Azambuja E, et al. Among authors: bliss j. ESMO Open. 2024 Nov;9(11):103938. doi: 10.1016/j.esmoop.2024.103938. Epub 2024 Oct 17. ESMO Open. 2024. PMID: 39418883 Free PMC article. Clinical Trial.
What is the carbon footprint of academic clinical trials? A study of hotspots in 10 trials.
Griffiths J, Adshead F, Al-Shahi Salman R, Anderson C, Bedson E, Bliss J, Boshoff A, Chen X, Cranley D, Doran P, Dunne F, Gamble C, Gillies K, Hood K, Kavanagh C, Malone J, McGregor N, McNamara C, Midha E, Moore K, Murphy L, Newman C, O'Reilly S, Perkins AM, Pett S, Sydes MR, Whitty L, You F, Fox L, Williamson PR. Griffiths J, et al. Among authors: bliss j. BMJ Open. 2024 Oct 16;14(10):e088600. doi: 10.1136/bmjopen-2024-088600. BMJ Open. 2024. PMID: 39414270 Free PMC article.
Antibiotic exposure for culture-negative early-onset sepsis in late-preterm and term newborns: an international study.
Dimopoulou V, Klingenberg C, Navér L, Nordberg V, Berardi A, El Helou S, Fusch G, Bliss JM, Lehnick D, Guerina N, Seliga-Siwecka J, Maton P, Lagae D, Mari J, Janota J, Agyeman PKA, Pfister R, Latorre G, Maffei G, Laforgia N, Mózes E, Størdal K, Strunk T, Stocker M, Giannoni E; AENEAS Study Group. Dimopoulou V, et al. Among authors: bliss jm. Pediatr Res. 2024 Sep 17. doi: 10.1038/s41390-024-03532-6. Online ahead of print. Pediatr Res. 2024. PMID: 39289592
Adjuvant Pertuzumab and Trastuzumab in Early Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer in the APHINITY Trial: Third Interim Overall Survival Analysis With Efficacy Update.
Loibl S, Jassem J, Sonnenblick A, Parlier D, Winer E, Bergh J, Gelber RD, Restuccia E, Im YH, Huang CS, Dalenc F, Calvo I, Procter M, Caballero C, Clark E, Raimbault A, McConnell R, Monturus E, de Azambuja E, Gomez HL, Bliss J, Viale G, Bines J, Piccart M; APHINITY Steering Committee and Investigators. Loibl S, et al. Among authors: bliss j. J Clin Oncol. 2024 Nov;42(31):3643-3651. doi: 10.1200/JCO.23.02505. Epub 2024 Sep 11. J Clin Oncol. 2024. PMID: 39259927 Clinical Trial.
Correction: Neonatal sepsis definitions from randomised clinical trials.
Hayes R, Hartnett J, Semova G, Murray C, Murphy K, Carroll L, Plapp H, Hession L, O'Toole J, McCollum D, Roche E, Jenkins E, Mockler D, Hurley T, McGovern M, Allen J, Meehan J, Plötz FB, Strunk T, de Boode WP, Polin R, Wynn JL, Degtyareva M, Küster H, Janota J, Giannoni E, Schlapbach LJ, Keij FM, Reiss IKM, Bliss J, Koenig JM, Turner MA, Gale C, Molloy EJ; Infection, Inflammation, Immunology and Immunisation (I4) section of the European Society for Paediatric Research (ESPR). Hayes R, et al. Among authors: bliss j. Pediatr Res. 2024 Jul 29. doi: 10.1038/s41390-024-03416-9. Online ahead of print. Pediatr Res. 2024. PMID: 39075169 Free article. No abstract available.
515 results